Stryker Corp
SYK378.950USD
+2.340+0.62%
Close 08/13, 16:00（ET）Quotes delayed by 15 min
144.87BMarket Cap
50.67P/E TTM
More Details of Stryker Corp Company
Stryker Corporation (Stryker) is a medical technology company. It offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products. It also develops neurointerventional devices for the treatment of intracranial aneurysms. It offers Fortress, a modular wall system for hospitals and ambulatory surgery centers. It specializes in soft tissue fixation products and delivering AI-assisted virtual care workflows.
Company Info
Ticker SymbolSYK
Company nameStryker Corp
IPO dateMar 17, 1980
CEOMr. Kevin A. Lobo
Number of employees53000
Security typeOrdinary Share
Fiscal year-endMar 17
Address1941 Stryker Way
CityPORTAGE
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code49002
Phone12693852600
Websitehttps://www.stryker.com/
Ticker SymbolSYK
IPO dateMar 17, 1980
CEOMr. Kevin A. Lobo
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
Group President - Orthopaedics and Spine
Group President - Orthopaedics and Spine
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.90K
+1.24%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
13.19K
+42.64%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
9.94K
-4.25%
Mr. Preston W. Wells
Mr. Preston W. Wells
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
7.25K
--
Ms. Mary K. Brainerd
Ms. Mary K. Brainerd
Independent Director
Independent Director
6.38K
+9.63%
Mr. Rajeev Suri
Mr. Rajeev Suri
Independent Director
Independent Director
5.78K
+10.74%
Dr. Giovanni Caforio, M.D.
Dr. Giovanni Caforio, M.D.
Independent Director
Independent Director
2.80K
+25.01%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
Group President - Orthopaedics and Spine
Group President - Orthopaedics and Spine
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.90K
+1.24%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
13.19K
+42.64%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
9.94K
-4.25%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Trauma and Extremities
945.00M
16.11%
Medical
945.00M
16.11%
Endoscopy
867.00M
14.78%
Instruments
730.00M
12.44%
Knees
639.00M
10.89%
Other
1.74B
29.66%
By RegionUSD
Name
Revenue
Proportion
United States
4.44B
75.69%
International
1.43B
24.31%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Trauma and Extremities
945.00M
16.11%
Medical
945.00M
16.11%
Endoscopy
867.00M
14.78%
Instruments
730.00M
12.44%
Knees
639.00M
10.89%
Other
1.74B
29.66%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.72%
Brown (John W)
5.25%
Greenleaf Trust
4.37%
BlackRock Institutional Trust Company, N.A.
4.21%
State Street Global Advisors (US)
3.87%
Other
73.59%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.72%
Brown (John W)
5.25%
Greenleaf Trust
4.37%
BlackRock Institutional Trust Company, N.A.
4.21%
State Street Global Advisors (US)
3.87%
Other
73.59%
Shareholder Types
Shareholders
Proportion
Investment Advisor
45.48%
Investment Advisor/Hedge Fund
20.93%
Bank and Trust
6.57%
Individual Investor
5.36%
Research Firm
3.27%
Pension Fund
2.04%
Sovereign Wealth Fund
1.32%
Hedge Fund
0.82%
Family Office
0.13%
Other
14.08%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
3464
329.22M
86.11%
-1.59M
2025Q1
3477
331.34M
86.70%
+478.07K
2024Q4
3392
326.31M
85.52%
-6.25M
2024Q3
3219
327.28M
85.85%
-2.63M
2024Q2
3172
322.05M
84.52%
-4.86M
2024Q1
3130
320.11M
84.03%
-8.55M
2023Q4
3047
327.61M
86.24%
+19.84M
2023Q3
2938
324.92M
85.54%
+14.80M
2023Q2
2898
325.04M
85.60%
+10.05M
2023Q1
2838
330.33M
87.03%
+17.40M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
32.91M
8.61%
+360.08K
+1.11%
Mar 31, 2025
Brown (John W)
20.06M
5.25%
--
--
Feb 28, 2025
Greenleaf Trust
17.12M
4.48%
-272.70K
-1.57%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
16.59M
4.34%
+5.35K
+0.03%
Mar 31, 2025
State Street Global Advisors (US)
14.81M
3.87%
+27.41K
+0.19%
Mar 31, 2025
T. Rowe Price Associates, Inc.
11.62M
3.04%
+1.01M
+9.53%
Mar 31, 2025
Geode Capital Management, L.L.C.
7.31M
1.91%
+240.40K
+3.40%
Mar 31, 2025
JP Morgan Asset Management
7.47M
1.95%
+669.18K
+9.84%
Mar 31, 2025
Fidelity Management & Research Company LLC
7.19M
1.88%
-178.77K
-2.43%
Mar 31, 2025
Capital Research Global Investors
6.86M
1.8%
+22.70K
+0.33%
Mar 31, 2025
View more
Related ETFs
Updated: Wed, Aug 6
Updated: Wed, Aug 6
Name
Proportion
Jensen Quality Growth ETF
6.73%
iShares U.S. Medical Devices ETF
4.57%
Gabelli Growth Innovators ETF
4.29%
AdvisorShares Focused Equity ETF
4%
JPMorgan Healthcare Leaders ETF
3.67%
Tema Neuroscience and Mental Health ETF
3.55%
Knowledge Leaders Developed World ETF
3.21%
Global X Aging Population ETF
3.2%
Hennessy Sustainable ETF
3.04%
AdvisorShares Gerber Kawasaki ETF
2.87%
View more
Jensen Quality Growth ETF
Proportion6.73%
iShares U.S. Medical Devices ETF
Proportion4.57%
Gabelli Growth Innovators ETF
Proportion4.29%
AdvisorShares Focused Equity ETF
Proportion4%
JPMorgan Healthcare Leaders ETF
Proportion3.67%
Tema Neuroscience and Mental Health ETF
Proportion3.55%
Knowledge Leaders Developed World ETF
Proportion3.21%
Global X Aging Population ETF
Proportion3.2%
Hennessy Sustainable ETF
Proportion3.04%
AdvisorShares Gerber Kawasaki ETF
Proportion2.87%
Dividend
A total of
5.22B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Dec 10, 2024
SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 09, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 31, 2024
Jun 28, 2024
Feb 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 05, 2023
SYK.NB Final Cash Dividend of gross USD 0.8 paid on Jan 31, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 31, 2024
Dec 28, 2023
Aug 02, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Oct 31, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 10, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 31, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 31, 2023
Jun 29, 2023
Feb 09, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 28, 2023 going ex on Mar 30, 2023
Mar 31, 2023
Apr 28, 2023
Mar 30, 2023
Dec 07, 2022
SYK.NB Final Cash Dividend of gross USD 0.75 paid on Jan 31, 2023 going ex on Dec 29, 2022
Dec 30, 2022
Jan 31, 2023
Dec 29, 2022
Aug 03, 2022
SYK.NB Interim Cash Dividend of gross USD 0.695 paid on Oct 31, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 31, 2022
Sep 29, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
